Navigation Links
Michigan Business & Professional Association Urges Legislature to Act Quickly on Individual Health Care Reform
Date:11/10/2008

WARREN, Mich., Nov. 10 /PRNewswire-USNewswire/ -- The weak Michigan economy, rising health care costs, staggering business tax increases, and increased energy costs are all converging to create a perfect storm for Michigan's small business community. And a critical lifeline -- affordable health care coverage through Blue Cross Blue Shield of Michigan -- is in danger of being lost, according to the Michigan Business and Professional Association and its sister organization, the Michigan Food and Beverage Association, representing more than 20,000 business members that employ over 180,000 individuals throughout the State of Michigan.

"Individual health care reform is needed now in Michigan to ensure the financial stability of our members and all small businesses," said Jennifer Kluge, associations' chief operating officer. "We receive countless phone calls a week from our members possibly canceling their group health insurance because they can no longer afford it and this year has been the worst."

Kluge explained that cancellation of any small business' health care coverage causes its employees to be thrust into the marketplace to shop for their own health care (sometimes with lesser coverage), often a daunting task which potentially puts millions of people at risk of having no coverage at all.

"We need the legislature to act now on individual health care reform by supporting House Bills 5282 and 5283," said Kluge. "It's up to our elected representatives to protect the health care of our members and millions of people in Michigan who desperately need it in these tough economic times."

When employees who have lost coverage go to the market, it's often the case that the younger and healthier individuals are offered lower-priced coverage from private insurance companies, leaving the older, less healthy and at-risk population being covered by Blue Cross Blue Shield of Michigan, as the state's insurer of last resort.

"This current s
'/>"/>

SOURCE Michigan Business & Professional Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Health Plan of Michigan Ranked Among Nations Best Medicaid Health Plans in 2008
2. The University of Michigan Welcomes Passage of Proposal 2
3. Compuware Covisint to Securely Connect, Integrate Michigans Thumb Health Information System
4. Blue Cross Blue Shield of Michigan Closes Detroit Operations October 31 Due to Bomb Threat
5. Meijer Honored by Michigan Primary Care Association for Leadership in Promoting Health of Michigan Residents
6. Blue Cross Blue Shield of Michigan Foundation Grant to Eastern Michigan University Will Help Ypsilanti Elementary Schoolchildren Lead Healthier Lives
7. Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan
8. 3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
9. Michigan Success Lands National Research Contract to Reduce Hospital-Associated Infections in 10 States
10. Alert Alarm Michigan Seeks Employees With Inside and Outside Sales Experience
11. Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., ANAHEIM, Calif., Dec. 4 Pamela ...hcare, was selected as a finalist for the "Chief I...scent,s business with the power of cloud computing...ir innovative usage of Salesforce CRM or the Force...uccess to their sales, marketing, partner, service...
(Date:12/4/2009)... with mice, scientists at Johns Hopkins publishing...hat a protein made by a gene called "Twist" may be...nguish stem cells that drive aggressive, metastati..., Building on recent work suggesting that it is a ...umors that drives breast cancer, scientists have s...
(Date:12/4/2009)...me whether procedure done immediately or 3 weeks l...althDay News) -- Timing of surgical repair or reco...not affect patient outcome, a new study has found....traumatic knee dislocations that can occur in high...mal time to perform surgery to repair these injuri...
(Date:12/4/2009)...d surveillance urged for at-risk patient groups ,...e childhood cancers, particularly Ewing sarcomas a...f late recurrence, U.S. researchers have found. ,...e-year survivors of the most common pediatric canc...ivor Study. , The researchers found that the ov...
(Date:12/4/2009)... found they spurred blood vessel growth after hear...ews) -- Adult stem cells appear to help repair hea...e 1 study of 53 patients found that stem cells fro...od vessels in heart tissue damaged by heart attack...ons within 10 days of having a heart attack. Durin...
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...o be the most powerful indicator of heart disease....reased levels of total amount cholesterol in blood...tein)or 'bad' cholesterol and HDL(High-Density Lip...d molecule called// apolipoprotein, which they bel...
...s the world over, with India being touted as the "...erious diseases that diabetics can be affected wit...the deterioration of nerves in the body. A diabeti...abetes will develop// neuropathy. A study by ...
...uing the field of medicine and patients are now de... medical error happens. However, doctors are often...ey do not care. In fact, doctors confessed to bein...ng patients, doctors, and// patients and doctors t...
...eceived a patient, a two-month-old baby with white...are disease caused due to a deficiency of lipoprot... 10 million children. Doctors said that the baby w...his condition could be either due to// ‘familial l...
...a common genetic mutation called C150T transition ...scovering a "fountain of youth". This genetic muta...lood cells, in a study of a group of 52 Italian ce...he age// of 99. Mitochondria are so-called "o...
...ersity of Rochester, New York suggests that the ac...mmatory and anti-coagulant properties,which until ...also help reduce the damage caused by stroke. Rese...ng apoptosis, a form of programmed cell death. The...
Other Medicine News:
(Date:12/4/2009)...c. 4 Suneva Medical, a privately-h...ced the appointment of Philip Ranker as Vice Presi...r. Ranker will lead all Suneva Medical,s general a...ounting, IT, IR, administration and human resource...agement team. ,, "One of my key objectives as ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawf...n (PSA) recurrence from the additional analysis of...te in a Phase III pivotal study of FIRMAGON® ...olide in prostate cancer patients during the first...received FIRMAGON 240/80 mg/month had a recurrence...
(Date:12/3/2009)... Allen Medical Systems, ...RC ), today announced the launch of its new Allen ...business website www.AllenAmatech.com . ,, ... identity and includes an online version of the ne...design specifications for the products. "We hope t...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 1Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 3AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 1AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 2AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 3Hartford grants increase support for geriatric social work training 49209 1Hartford grants increase support for geriatric social work training 49209 2Hartford grants increase support for geriatric social work training 49209 3
...ne in the Treatment of Patients with Relapsed/Ref...ented Tomorrow, Tuesday, June 3rd at 12:0...rmaceuticals,Inc. (Nasdaq: KERX ) today announced...ave been selected for both poster presentation and...al Oncology Meeting,currently taking place in Chic...
...erican Society of Clinical Oncology (ASCO),annual ...vival vs. external c...c.,(Nasdaq: IDMI ) today announced follow-up resu...t the product candidate was well tolerated, induce...sponses, and showed a,positive survival trend in H...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 4Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 5IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 2IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 3IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 4
Disposable Lacrimal Dilators
Reusable Double Dilators
Skin Tone External Eyelid Weights
Contour Design Eyelid Implants (Gold)
Medicine Products: